132 related articles for article (PubMed ID: 31933473)
1. Off-label prescribing during pregnancy in France: the NéHaVi cohort
.
Laroche ML; Blin A; Coubret A; Grau M; Roux B; Aubard Y
Int J Clin Pharmacol Ther; 2020 Apr; 58(4):198-208. PubMed ID: 31933473
[TBL] [Abstract][Full Text] [Related]
2. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
3. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions and off-label drug use in paediatric outpatients.
Horen B; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2002 Dec; 54(6):665-70. PubMed ID: 12492616
[TBL] [Abstract][Full Text] [Related]
5. Drug prescribing before and during pregnancy in south west France: a retrolective study.
Crespin S; Bourrel R; Hurault-Delarue C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Drug Saf; 2011 Jul; 34(7):595-604. PubMed ID: 21663335
[TBL] [Abstract][Full Text] [Related]
6. Prescription of hazardous drugs during pregnancy.
Malm H; Martikainen J; Klaukka T; Neuvonen PJ
Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977
[TBL] [Abstract][Full Text] [Related]
7. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
[TBL] [Abstract][Full Text] [Related]
8. Mobile phone use during pregnancy: Which association with fetal growth?
Boileau N; Margueritte F; Gauthier T; Boukeffa N; Preux PM; Labrunie A; Aubard Y
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101852. PubMed ID: 32623065
[TBL] [Abstract][Full Text] [Related]
9. Prescription drug use in pregnancy and variations according to prior psychiatric history.
Ingstrup KG; Liu X; Gasse C; Debost JP; Munk-Olsen T
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):105-113. PubMed ID: 29171114
[TBL] [Abstract][Full Text] [Related]
10. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
11. Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland.
Irvine L; Flynn RW; Libby G; Crombie IK; Evans JM
Drug Saf; 2010 Jul; 33(7):593-604. PubMed ID: 20553060
[TBL] [Abstract][Full Text] [Related]
12. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
13. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
14. Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems.
Blotière PO; Damase-Michel C; Weill A; Maura G
Drug Saf; 2021 Dec; 44(12):1323-1339. PubMed ID: 34613596
[TBL] [Abstract][Full Text] [Related]
15. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital.
Herring C; McManus A; Weeks A
Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674
[TBL] [Abstract][Full Text] [Related]
16. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
17. [Prescribed and dispensed in the third trimester of pregnancy drugs: What practices and risks?].
Parent G; Mottet N; Mairot P; Baudier F; Carel D; Goguey M; Riethmuller D; Limat S
J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):754-9. PubMed ID: 26481682
[TBL] [Abstract][Full Text] [Related]
18. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
19. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
Hurault-Delarue C; Chouquet C; Savy N; Lacroix I; Beau AB; Montastruc JL; Damase-Michel C
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):770-7. PubMed ID: 27018245
[TBL] [Abstract][Full Text] [Related]
20. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
